Chapter Two · MGRS
One of the things people type into Google most is MGUS but my kidney numbers are getting worse
.
MGUS means a rogue protein and no harm found yet. MGRS means the protein has found the kidney. The difference is a test most people are never offered. This chapter names it.
One doctor watches the protein. Another watches the kidneys. The gap between them is where this lives.
Start with a phone call. Your doctor’s office has a triage line and a nurse will talk it through with you. They are good at this, they do it all day, and it costs nothing. You ring the main number and ask for the triage nurse. There is no charge and you do not need an appointment.
If it feels more serious than that, go to urgent care. You will usually be seen faster than at a hospital.
If it feels life-threatening — chest pain, trouble breathing, confusion, no urine at all for a day — call 911 or go to the emergency room. Do not wait until you are sure. Take the more cautious road.
Rather listen?
Takes about 10 minutes, read aloud. It is the same words as the page below, so nothing is missing if you would rather read. Download it to keep on your phone — it will play with no signal, in a waiting room or a car.
A small group of cells in the bone marrow makes one abnormal antibody protein.
Too few cells to count as a cancer — but the protein they make can damage a kidney
directly.
→ where this is explained: What MGRS actually is
The word that causes the trouble is “benign”. The same protein
finding, without organ damage, is called MGUS and is genuinely watched rather than
treated. With kidney damage it is a different situation with a different name.
→ where this is explained: Why it takes years
Three blood and urine tests find most of it, and they are often not ordered
together.
→ where this is explained: The tests to ask about
Tick the ones that apply. The bar below shows how much they add up to.
What we would do, as a friend rather than as your doctor. This is our opinion and we stand behind it. It is not medical advice and we are not examining you.
It is not a one-time reading. If you start feeling worse while you are deciding, move up a level. Nobody has ever been criticised for turning up and being sent home. A false alarm is the best possible outcome here.
If none of these apply, the rest of this chapter is worth your time. Take it slowly; there is no clock on it.
Bone marrow makes plasma cells, and plasma cells make antibodies. In this condition a small clone of abnormal plasma cells makes one antibody over and over — identical copies, which is why it is called monoclonal.
Three situations share that finding and are not the same thing:
MGUS — the abnormal protein is present and no organ is being harmed. It is monitored. No treatment.
Multiple myeloma — the clone has grown large enough to meet the criteria for a cancer, and is treated as one.
MGRS — the clone is too small to meet those criteria, and the protein it makes is toxic to the kidney. Not a cancer. Not harmless either.
Grade A MGRS was only defined as a separate entity in 2012. Many practising doctors trained before that, and learned that the underlying finding is benign and needs only watching. The idea that it can seriously damage a kidney is newer than most of the careers now treating it.
The referral split. You see a primary care doctor for tiredness and swollen legs. Blood tests show kidney function slipping and protein in the urine, so you are sent to a kidney specialist, who calls it chronic kidney disease and treats the blood pressure. Separately, routine blood work shows an odd protein band, so you are sent to a blood specialist, who calls it MGUS and books a yearly check. Both are doing their jobs. Neither one owns the question of whether the first thing is causing the second.
The biopsy hesitation. Recognising MGRS in the kidney generally needs a kidney biopsy showing the protein deposited in the tissue. Where a plausible cause is already on the chart — diabetes, high blood pressure — a biopsy can look unnecessary, so the deposits are never looked for.
The threshold problem. The criteria for myeloma are thresholds: how much protein, what share of the marrow. MGRS sits below them. The tests report “not cancer”, which is true, and nobody asks the different question of whether the protein is harming the kidney.
Diabetic kidney disease. Both leak protein and both reduce filtering. The distinguishing point: diabetic kidney damage heavy enough to cause very heavy protein loss is normally accompanied by diabetic changes in the eyes. Heavy protein loss with healthy eyes is a mismatch.
Kidney damage from high blood pressure. The usual default where blood pressure has been high for years. The distinguishing point: it rarely causes heavy protein loss on its own.
“Idiopathic” membranous nephropathy. Idiopathic means the cause was not identified. The distinguishing point: if the biopsy staining shows only one light chain type — kappa or lambda, not both — the cause has in fact been identified, and it is this one.
C3 glomerulopathy. Both can show complement deposits. More than that: in adults this condition can be the cause of C3G, with the abnormal protein interfering with the complement system. That link is covered in the C3G room.
Serum protein electrophoresis, with immunofixation. The basic blood screen. Electrophoresis alone misses small amounts; immunofixation is the sensitive part, and is often only run if it is specifically requested. Ask for both.
Urine protein electrophoresis, with immunofixation. Some abnormal proteins show in urine and not in blood. It needs a properly collected 24-hour urine; a random sample can miss it.
Serum free light chain assay. Measures the two light chain types and the ratio between them. Grade A This can be abnormal when both electrophoresis tests look normal, so an abnormal ratio alongside kidney trouble is worth following up rather than filing.
Kidney biopsy with the right staining. Where it is being looked for specifically, the request matters: light microscopy, immunofluorescence for kappa and lambda, and electron microscopy. Standard immunofluorescence on frozen tissue can read falsely negative; a pronase-digested paraffin technique picks up deposits it misses.
“I have both kidney trouble and a monoclonal protein. Has anyone looked at whether the protein is causing the kidney damage?”
“On my kidney biopsy — did the immunofluorescence show only one light chain, kappa or lambda, rather than both?”
“If this is MGRS, what is the plan for treating the clone, to protect the kidney function I still have?”
“Should I be seen somewhere that has both blood and kidney specialists working on monoclonal gammopathies together?”
“If I am being told this is just MGUS — then why is there significant protein in my urine and why is my filtering falling?”
Having diabetes does not settle it. A person can have diabetic kidney disease and this at the same time.
A normal serum electrophoresis does not settle it either. Light-chain-only disease produces no visible spike; the free light chain assay is what catches it.
“Monitoring” belongs to the situation without organ damage. Where the kidney is involved, the situation has a different name and a different plan.
The clone can be small enough to be missed by a standard marrow biopsy read under the microscope. Sensitive flow cytometry finds clones that the eye does not.
A free app called Insight Kidney walks through the kidney from the whole organ down to a single filter, and shows what an abnormal protein does to the filters it lands in. It is the clearest picture of this we have found, and some people take in a shape far faster than a paragraph.
It is made by Anima Res, a German medical animation studio, and it was paid for by Novartis, who sell drugs for some of these conditions. We have no connection to either one. We link it because the anatomy is good, and we name who paid so you can weigh that yourself.
It is a phone app, and it opens outside this book. App Store · Google Play · what it is
Next chapter: My biopsy came back saying C3
Sections and clinical substance from MGRS-Disease-Room.html,
built 4 May 2026, recovered from the archive on 8 September 2026 and rewritten for this
site. Nothing on this page comes from any individual’s medical record.